Immunotherapy and CSCs

Cancer immunotherapy has shown great promise in recent years, but its effectiveness against cancer stem cells (CSCs) remains a challenge. This track explores how immunotherapy approaches, such as CAR T-cells, immune checkpoint inhibitors, and cancer vaccines, can be used to target and eliminate CSCs. Researchers study the immune evasion strategies employed by CSCs and how these cells can be made more vulnerable to immune-mediated destruction. By developing immunotherapies that specifically target CSCs, this research aims to enhance the overall success of cancer treatments, reduce the risk of recurrence, and improve long-term survival rates for cancer patients.

    Related Conference of Immunotherapy and CSCs

    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    October 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    Zurich, Switzerland
    November 20-21, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain
    December 08-09, 2025

    13th Euro Breast Cancer and Therapeutics

    Aix-en-Provence, France
    February 05-06, 2026

    11th World Conference on Breast and Cervical Cancer

    Paris, France
    February 12-13, 2026

    4th World Congress on Oral Cancer

    Singapore City, Singapore
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 23-24, 2026

    16th World Congress on Breast Cancer Research & Therapies

    Aix-en-Provence, France
    June 18-19, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France

    Immunotherapy and CSCs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in